Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Aeterna Zentaris stock

Learn how to easily invest in Aeterna Zentaris stock.

Aeterna Zentaris Inc is a biotechnology business based in the US. Aeterna Zentaris shares (AEZS) are listed on the NASDAQ and all prices are listed in US Dollars. Aeterna Zentaris employs 12 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aeterna Zentaris

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AEZS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aeterna Zentaris stock price (NASDAQ: AEZS)

Use our graph to track the performance of AEZS stocks over time.

Aeterna Zentaris shares at a glance

Information last updated 2022-01-25.
Latest market close$0.36
52-week range$0.30 - $3.62
50-day moving average $0.42
200-day moving average $0.69
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.07

Buy Aeterna Zentaris shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aeterna Zentaris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aeterna Zentaris price performance over time

Historical closes compared with the close of $0.355 from 2022-01-26

1 week (2022-01-16) N/A
1 month (2021-12-23) -15.52%
3 months (2021-10-23) N/A
6 months (2021-07-27) -53.29%
1 year (2021-01-27) -52.67%
2 years (2020-01-27) -70.42%
3 years (2019-01-25) 3.63
5 years (2017-01-27) 2.55

Aeterna Zentaris financials

Revenue TTM $4.2 million
Gross profit TTM $1.3 million
Return on assets TTM -7.1%
Return on equity TTM -17.3%
Profit margin -156.35%
Book value $0.49
Market capitalisation $42 million

TTM: trailing 12 months

Aeterna Zentaris share dividends

We're not expecting Aeterna Zentaris to pay a dividend over the next 12 months.

Have Aeterna Zentaris's shares ever split?

Aeterna Zentaris's shares were split on a 1:100 basis on 19 November 2015. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aeterna Zentaris shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Aeterna Zentaris shares which in turn could have impacted Aeterna Zentaris's share price.

Aeterna Zentaris share price volatility

Over the last 12 months, Aeterna Zentaris's shares have ranged in value from as little as $0.2971 up to $3.62. A popular way to gauge a stock's volatility is its "beta".

AEZS.US volatility(beta: 2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aeterna Zentaris's is 2.0044. This would suggest that Aeterna Zentaris's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aeterna Zentaris overview

Aeterna Zentaris Inc. , a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen name. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. It also has a license agreement with Consilient Health Ltd.

Frequently asked questions

What percentage of Aeterna Zentaris is owned by insiders or institutions?
Currently 0.072% of Aeterna Zentaris shares are held by insiders and 3.998% by institutions.
How many people work for Aeterna Zentaris?
Latest data suggests 12 work at Aeterna Zentaris.
When does the fiscal year end for Aeterna Zentaris?
Aeterna Zentaris's fiscal year ends in December.
Where is Aeterna Zentaris based?
Aeterna Zentaris's address is: 315 Sigma Drive, Summerville, SC, United States, 29486
What is Aeterna Zentaris's ISIN number?
Aeterna Zentaris's international securities identification number is: CA0079754028
What is Aeterna Zentaris's CUSIP number?
Aeterna Zentaris's Committee on Uniform Securities Identification Procedures number is: 007975105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site